Kids Favor Pump over Injections

NOVEMBER 01, 2003

    Investigators reported in Pediatrics (September 2003) that intensive insulin therapy is doable and safe for children with type 1 diabetes. A small study found that more children preferred treatment with continuous subcutaneous insulin infusion (CSII), compared with multiple daily insulin (MDI) injections. In the study, 23 participants, who ranged in age from 8 to 14 years, were randomly assigned to 1 of the 2 treatment methods. After receiving 1 treatment, the subjects were then switched to the other treatment.

    Glucose control increased significantly between an initial educational session and the start of the 7-month trial. At the end of the study, glucose levels did not differ significantly between treatment arms. Total daily insulin dose decreased, however, during CSII therapy and increased during MDI injections, according to the study results.



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

Pharmacy Times Strategic Alliance
 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.